271 related articles for article (PubMed ID: 31408480)
1. Development of an electronic medical record-based algorithm to identify patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan.
Fukasawa T; Takahashi H; Kameyama N; Fukuda R; Furuhata S; Tanemura N; Amagai M; Urushihara H
PLoS One; 2019; 14(8):e0221130. PubMed ID: 31408480
[TBL] [Abstract][Full Text] [Related]
2. Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases.
Davis RL; Gallagher MA; Asgari MM; Eide MJ; Margolis DJ; Macy E; Burmester JK; Selvam N; Boscarino JA; Cromwell LF; Feigelson HS; Kuntz JL; Pawloski PA; Penfold RB; Raebel MA; Sridhar G; Wu A; La Grenade LA; Pacanowski MA; Pinheiro SP
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):684-92. PubMed ID: 25914229
[TBL] [Abstract][Full Text] [Related]
3. Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink.
Frey N; Bircher A; Bodmer M; Jick SS; Meier CR; Spoendlin J
Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):429-436. PubMed ID: 27868282
[TBL] [Abstract][Full Text] [Related]
4. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
[TBL] [Abstract][Full Text] [Related]
5. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.
Lebrun-Vignes B; Guy C; Jean-Pastor MJ; Gras-Champel V; Zenut M;
Br J Clin Pharmacol; 2018 Feb; 84(2):331-338. PubMed ID: 28963996
[TBL] [Abstract][Full Text] [Related]
6. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
Sunaga Y; Kurosawa M; Ochiai H; Watanabe H; Sueki H; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Mizukawa Y; Ohyama M; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Takahashi H; Mieno H; Ueta M; Sotozono C; Niihara H; Morita E; Kokaze A
J Dermatol Sci; 2020 Dec; 100(3):175-182. PubMed ID: 33046331
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.
Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
PLoS One; 2016; 11(11):e0165933. PubMed ID: 27835661
[TBL] [Abstract][Full Text] [Related]
8. Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database study.
Guzman AK; Zhang M; Kwatra SG; Kaffenberger BH
J Am Acad Dermatol; 2020 Feb; 82(2):303-310. PubMed ID: 31542405
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
[TBL] [Abstract][Full Text] [Related]
10. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
12. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.
Yamane Y; Aihara M; Ikezawa Z
Allergol Int; 2007 Dec; 56(4):419-25. PubMed ID: 17713361
[TBL] [Abstract][Full Text] [Related]
14. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review.
Weinkle A; Pettit C; Jani A; Keller J; Lu Y; Malachowski S; Trinidad JC; Kaffenberger BH; Ergen EN; Hughey LC; Smith D; Seminario-Vidal L
J Am Acad Dermatol; 2019 Sep; 81(3):749-757. PubMed ID: 31150704
[TBL] [Abstract][Full Text] [Related]
16. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
17. Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).
Velasco-Tirado V; Alonso-Sardón M; Cosano-Quero A; Romero-Alegría Á; Sánchez-Los Arcos L; López-Bernus A; Pardo-Lledías J; Belhassen-García M
PLoS One; 2018; 13(6):e0198582. PubMed ID: 29912947
[TBL] [Abstract][Full Text] [Related]
18. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK.
Frey N; Jossi J; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
J Invest Dermatol; 2017 Jun; 137(6):1240-1247. PubMed ID: 28202399
[TBL] [Abstract][Full Text] [Related]
19. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.
Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB
Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749
[TBL] [Abstract][Full Text] [Related]
20. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
Frey N; Bodmer M; Bircher A; Rüegg S; Jick SS; Meier CR; Spoendlin J
Epilepsia; 2017 Dec; 58(12):2178-2185. PubMed ID: 29027197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
